Diabetes Information Center

News

Empagliflozin Reduces Risk for Nephropathy Regardless of Blood Pressure, LDL Cholesterol, HbA1c

Empagliflozin Reduces Risk for Nephropathy Regardless of Blood Pressure, LDL Cholesterol, HbA1c

Investigators examined renal outcomes when controlling cardiovascular risk factors, such as blood pressure, LDL-C, and HbA1c.

ITCA 650 Shows Efficacy in Reducing Weight, HbA1c in Type 2 Diabetes

The ITCA 650, a small titanium osmotic mini-pump, provides a subcutaneous infusion of exenatide over 3 or 6 months.

MEDI0382 Safe, Effective for Normalizing Glucose, Weight Loss in Type 2 Diabetes

MEDI0382 reduced body weight and normalized fasting and postprandial blood glucose levels in patients with type 2 diabetes.

Opinion

ACP supports higher HbA1c targets for pharmacotherapy in adults with T2D

ACP responds to criticism from the ADA, the Endocrine Society, the AACE, and the AADE of guidance that clinicians should aim to achieve an HbA1c level between 7% and 8% in most people with type 2 diabetes.

Clinical Features

Getting hemoglobin A1c under control after a relapse

Getting hemoglobin A1c under control after a relapse

A patient with diabetes questions the necessity of starting a statin.

Interventions for prediabetes

Interventions for prediabetes

Two clinicians disagree on a diagnosis after reviewing two-hour oral glucose tolerance test results. Who is correct?

Sign Up for Free e-newsletters